BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22093943)

  • 1. Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).
    Pesce GA; Klingbiel D; Ribi K; Zouhair A; von Moos R; Schlaeppi M; Caspar CB; Fischer N; Anchisi S; Peters S; Cathomas R; Bernhard J; Kotrubczik NM; D'Addario G; Pilop C; Weber DC; Bodis S; Pless M; Mayer M; Stupp R
    Eur J Cancer; 2012 Feb; 48(3):377-84. PubMed ID: 22093943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
    Sperduto PW; Wang M; Robins HI; Schell MC; Werner-Wasik M; Komaki R; Souhami L; Buyyounouski MK; Khuntia D; Demas W; Shah SA; Nedzi LA; Perry G; Suh JH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1312-8. PubMed ID: 23391814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
    BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study.
    Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N
    Clin Lung Cancer; 2010 May; 11(3):176-81. PubMed ID: 20439193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population.
    Ma S; Xu Y; Deng Q; Yu X
    Lung Cancer; 2009 Aug; 65(2):198-203. PubMed ID: 19091441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
    Addeo R; De Rosa C; Faiola V; Leo L; Cennamo G; Montella L; Guarrasi R; Vincenzi B; Caraglia M; Del Prete S
    Cancer; 2008 Nov; 113(9):2524-31. PubMed ID: 18798231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.
    Lin CH; Hsu KH; Chang SN; Tsou HK; Sheehan J; Sheu ML; Pan HC
    Radiat Oncol; 2015 Jun; 10():127. PubMed ID: 26048754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole brain reirradiation and concurrent temozolomide in patients with brain metastases.
    Minniti G; Scaringi C; Lanzetta G; Bozzao A; Romano A; De Sanctis V; Valeriani M; Osti M; Enrici RM
    J Neurooncol; 2014 Jun; 118(2):329-334. PubMed ID: 24718862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of temozolomide combined with whole brain radiotherapy for non-small cell lung cancer brain metastases.
    Zhu Y; Fu L; Jing W; Guo D; Kong L; Yu J
    Thorac Cancer; 2018 Sep; 9(9):1121-1128. PubMed ID: 29947170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial.
    Verger E; Gil M; Yaya R; Viñolas N; Villà S; Pujol T; Quintó L; Graus F
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):185-91. PubMed ID: 15629610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
    Tian J; Luo Y; Xiang J; Tang J
    J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.
    Hassler MR; Pfeifer W; Knocke-Abulesz TH; Geissler K; Altorjai G; Dieckmann K; Marosi C
    Wien Klin Wochenschr; 2013 Aug; 125(15-16):481-6. PubMed ID: 23907204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis.
    Zheng MH; Sun HT; Xu JG; Yang G; Huo LM; Zhang P; Tian JH; Yang KH
    Biomed Res Int; 2016; 2016():5807346. PubMed ID: 27006948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: a randomised phase II trial.
    Gamboa-Vignolle C; Ferrari-Carballo T; Arrieta Ó; Mohar A
    Radiother Oncol; 2012 Feb; 102(2):187-91. PubMed ID: 22257825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to prevent brain metastasis in high-risk non-small-cell lung cancer: lessons learned from a randomized study of maintenance temozolomide versus observation.
    Boggs DH; Robins HI; Langer CJ; Traynor AM; Berkowitz MJ; Mehta MP
    Clin Lung Cancer; 2014 Nov; 15(6):433-40. PubMed ID: 25069747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Whole brain radiation therapy plus temozolomide in the treatment of brain metastases from non small cell lung cancer: a meta-analysis].
    Liao K; Bi ZF; He Y; Liu YM
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(45):3199-203. PubMed ID: 23328466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study.
    Giorgio CG; Giuffrida D; Pappalardo A; Russo A; Santini D; Salice P; Blanco G; Castorina S; Failla G; Bordonaro R
    Lung Cancer; 2005 Nov; 50(2):247-54. PubMed ID: 16039010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell lung cancer: a retrospective study.
    Zeng YD; Zhang L; Liao H; Liang Y; Xu F; Liu JL; Dinglin XX; Chen LK
    Asian Pac J Cancer Prev; 2012; 13(3):909-14. PubMed ID: 22631670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.
    Wang Q; Jiang Z; Qi X; Lu S; Wang S; Leng C; Lu F; Liu H; Liang S; Shi J
    Clin Transl Oncol; 2014 Nov; 16(11):1000-5. PubMed ID: 24894840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
    Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
    Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.